Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options

Free radicals are common outcome of normal aerobic cellular metabolism. In-built antioxidant system of body plays its decisive role in prevention of any loss due to free radicals. However, imbalanced defense mechanism of antioxidants, overproduction or incorporation of free radicals from environment to living system leads to serious penalty leading to neuro-degeneration. Neural cells suffer functional or sensory loss in neurodegenerative diseases. Apart from several other environmental or genetic factors, oxidative stress (OS) leading to free radical attack on neural cells contributes calamitous role to neuro-degeneration. Though, oxygen is imperative for life, imbalanced metabolism and excess reactive oxygen species (ROS) generation end into a range of disorders such as Alzheimer’s disease, Parkinson’s disease, aging and many other neural disorders. Toxicity of free radicals contributes to proteins and DNA injury, inflammation, tissue damage and subsequent cellular apoptosis. Antioxidants are now being looked upon as persuasive therapeutic against solemn neuronal loss, as they have capability to combat by neutralizing free radicals. Diet is major source of antioxidants, as well as medicinal herbs are catching attention to be commercial source of antioxidants at present. Recognition of upstream and downstream antioxidant therapy to oxidative stress has been proved an effective tool in alteration of any neuronal damage as well as free radical scavenging. Antioxidants have a wide scope to sequester metal ions involved in neuronal plaque formation to prevent oxidative stress. In addition, antioxidant therapy is vital in scavenging free radicals and ROS preventing neuronal degeneration in post-oxidative stress scenario.

[1]  G. Heppner,et al.  Macrophage-mediated induction of drug-resistant variants in a mouse mammary tumor cell line. , 1986, Cancer research.

[2]  K. Ingold,et al.  Vitamin E as an in Vitro and in Vivo Antioxidant a , 1989, Annals of the New York Academy of Sciences.

[3]  S. Loft,et al.  Role of oxidative DNA damage in cancer initiation and promotion. , 1998, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[4]  C. Behl,et al.  The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Y. Henry,et al.  Quenching of the tyrosyl free radical of ribonucleotide reductase by nitric oxide. Relationship to cytostasis induced in tumor cells by cytotoxic macrophages. , 1994, The Journal of biological chemistry.

[6]  E. McGhee,et al.  Natural antimutagenic agents. , 1996, Mutation research.

[7]  C. Rae,et al.  Changes in Hepatic Glutathione Metabolism in Diabetes , 1991, Diabetes.

[8]  R. Floyd,et al.  Regional lipid peroxidation in rat brain in vitro: Possible role of endogenous iron , 1985, Neurochemical Research.

[9]  E. Flamm,et al.  The free radical pathology and the microcirculation in the major central nervous system disorders. , 1980, Acta physiologica Scandinavica. Supplementum.

[10]  K. Davies,et al.  Calcium and oxidative stress: from cell signaling to cell death. , 2002, Molecular immunology.

[11]  M. Mattson,et al.  Impairment of Glucose and Glutamate Transport and Induction of Mitochondrial Oxidative Stress and Dysfunction in Synaptosomes by Amyloid β‐Peptide: Role of the Lipid Peroxidation Product 4‐Hydroxynonenal , 1997, Journal of neurochemistry.

[12]  N. Baquer,et al.  Impaired antioxidant status in diabetic rat liver. Effect of vanadate. , 1993, Biochemical pharmacology.

[13]  J. Cooper,et al.  Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia. , 2000, Human molecular genetics.

[14]  W. Pryor,et al.  Free radical generation in the brain precedes hyperbaric oxygen-induced convulsions. , 1992, Free radical biology & medicine.

[15]  A. Bush,et al.  Metals and neuroscience. , 2000, Current opinion in chemical biology.

[16]  D. Butterfield,et al.  Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer’s disease brain contribute to neuronal death , 2002, Neurobiology of Aging.

[17]  U. Bandyopadhyay,et al.  Reactive oxygen species: oxidative damage and pathogenesis , 1999 .

[18]  I. Fridovich Fundamental Aspects of Reactive Oxygen Species, or What's the Matter with Oxygen? , 1999, Annals of the New York Academy of Sciences.

[19]  J. Cadet Free radical mechanisms in the central nervous system: an overview. , 1988, The International journal of neuroscience.

[20]  D Kromhout,et al.  Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. , 1995, Archives of internal medicine.

[21]  L. Bruijn,et al.  Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. , 1998, Science.

[22]  M. Mattson Will caloric restriction and folate protect against AD and PD? , 2003, Neurology.

[23]  B. D. Oomah,et al.  Antioxidant Activity and Total Phenolics in Selected Fruits, Vegetables, and Grain Products , 1998 .

[24]  M. Recio,et al.  Anti‐inflammatory and antioxidant properties of Helichrysum italicum , 2002, The Journal of pharmacy and pharmacology.

[25]  J. Baynes,et al.  Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. , 1999, Diabetes.

[26]  T. Yoshikawa Free radicals and their scavengers in Parkinson's disease. , 1993, European neurology.

[27]  Deborah Gustafson,et al.  Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. , 2004, Archives of neurology.

[28]  M. Youdim,et al.  Selective MAO-A and B inhibitors, radical scavengers and nitric oxide synthase inhibitors in Parkinson's disease. , 1994, Life sciences.

[29]  Colin L. Masters,et al.  Neurodegenerative diseases and oxidative stress , 2004, Nature Reviews Drug Discovery.

[30]  Xudong Huang,et al.  Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2). , 2002, The Journal of biological chemistry.

[31]  W. Burke,et al.  Taxol protects against calcium-mediated death of differentiated rat pheochromocytoma cells. , 1994, Life sciences.

[32]  B. Halliwell,et al.  Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? , 1994, The Lancet.

[33]  C. Négre [Treatment of Parkinson's disease]. , 1986, Soins; la revue de reference infirmiere.

[34]  G. Storz,et al.  Redox sensing by prokaryotic transcription factors. , 2000, Biochemical pharmacology.

[35]  G. L. West,et al.  Iron overload in Africa. Interaction between a gene and dietary iron content. , 1992, The New England journal of medicine.

[36]  Ian Parker,et al.  Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers*♦ , 2005, Journal of Biological Chemistry.

[37]  M. W. Anders,et al.  Targeting antioxidants to mitochondria: a new therapeutic direction. , 2006, Biochimica et biophysica acta.

[38]  C. Masters,et al.  Metalloenzyme-like Activity of Alzheimer's Disease β-Amyloid , 2002, The Journal of Biological Chemistry.

[39]  V. Papadopoulos,et al.  The Ginkgo biloba extract EGb 761 rescues the PC12 neuronal cells from β-amyloid-induced cell death by inhibiting the formation of β-amyloid-derived diffusible neurotoxic ligands , 2001, Brain Research.

[40]  C. S. Yang,et al.  Inhibition of carcinogenesis by dietary polyphenolic compounds. , 2001, Annual review of nutrition.

[41]  R. Martins,et al.  Amyloid-β: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-β , 2003, Brain Research Reviews.

[42]  R. Salganik The Benefits and Hazards of Antioxidants: Controlling Apoptosis and Other Protective Mechanisms in Cancer Patients and the Human Population , 2001, Journal of the American College of Nutrition.

[43]  B Chance,et al.  Hydroperoxide metabolism in mammalian organs. , 1979, Physiological reviews.

[44]  S. Imam,et al.  Possible Mechanism for the Neuroprotective Effects of l‐Carnitine on Methamphetamine‐Evoked Neurotoxicity , 2003, Annals of the New York Academy of Sciences.

[45]  J. McCord,et al.  The evolution of free radicals and oxidative stress. , 2000, The American journal of medicine.

[46]  E. Morgan,et al.  The Metabolism of Neuronal Iron and Its Pathogenic Role in Neurological Disease: Review , 2004, Annals of the New York Academy of Sciences.

[47]  S. Y. Wang,et al.  Antioxidant activity and phenolic compounds in selected herbs. , 2001, Journal of agricultural and food chemistry.

[48]  J. Stamler,et al.  Biochemistry of nitric oxide and its redox-activated forms. , 1992, Science.

[49]  K. Wakamatsu,et al.  The structure of neuromelanin as studied by chemical degradative methods , 2003, Journal of neurochemistry.

[50]  H. Hirt,et al.  Reactive oxygen species: metabolism, oxidative stress, and signal transduction. , 2004, Annual review of plant biology.

[51]  Jürgen Götz,et al.  Glial cells under physiologic and pathologic conditions. , 2002, Archives of neurology.

[52]  B. Mossman,et al.  Role of asbestos and active oxygen species in activation and expression of ornithine decarboxylase in hamster tracheal epithelial cells. , 1991, Cancer research.

[53]  B. Ames,et al.  Oxidants, antioxidants, and the degenerative diseases of aging. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Patrik Brundin,et al.  Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's disease. , 2002, Human molecular genetics.

[55]  Y. Muramatsu,et al.  Age-related changes in the concentrations of major and trace elements in the brain of rats and mice , 2001, Biological Trace Element Research.

[56]  S. Padmaja,et al.  The reaction of no with superoxide. , 1993, Free radical research communications.

[57]  Guoyao Wu,et al.  Free radicals, antioxidants, and nutrition. , 2002, Nutrition.

[58]  B. Winblad,et al.  Treating the full spectrum of dementia with memantine , 2003, International journal of geriatric psychiatry.

[59]  J. Valentine,et al.  Misfolded CuZnSOD and amyotrophic lateral sclerosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[60]  I. Young,et al.  The effects of desferrioxamine and ascorbate on oxidative stress in the streptozotocin diabetic rat. , 1995, Free radical biology & medicine.

[61]  R. Mason,et al.  The origin of the hydroxyl radical oxygen in the Fenton reaction. , 1997, Free radical biology & medicine.

[62]  Ralph A. Nixon,et al.  Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease , 2000, Nature.

[63]  C. Gérard,et al.  Complexes of iron(III) with ligands of biological interest: dopamine and 8-hydroxyquinoline-5-sulphonic acid , 1994 .

[64]  D. Harman,et al.  Free‐Radical Theory of Aging , 1994, Antioxidants & redox signaling.

[65]  V. Papadopoulos,et al.  The Ginkgo biloba extract EGB 761 rescues the PC12 neuronal cells from β-amyloid-induced cell death by inhibiting the formation of β-amyloid-derived diffusible neurotoxic ligands , 2000, Neurobiology of Aging.

[66]  J. Simpkins,et al.  Neuroprotective effects of estrogens: potential mechanisms of action , 2000, International Journal of Developmental Neuroscience.

[67]  B. P. Yu,et al.  Cellular defenses against damage from reactive oxygen species. , 1994, Physiological reviews.

[68]  Guido Kroemer,et al.  Mitochondrial control of cell death , 2000, Nature Medicine.

[69]  B. Halliwell,et al.  Antioxidants in human health and disease. , 1996, Annual review of nutrition.

[70]  H. Bartsch,et al.  The antioxidant/anticancer potential of phenolic compounds isolated from olive oil. , 2000, European journal of cancer.

[71]  R. Floyd,et al.  Free radical damage to protein and DNA: Mechanisms involved and relevant observations on brain undergoing oxidative stress , 1992, Annals of neurology.

[72]  K. C. Chang,et al.  Possible superoxide radical-induced alteration of vascular reactivity in aortas from streptozotocin-treated rats. , 1993, The Journal of pharmacology and experimental therapeutics.

[73]  J. Pommery,et al.  Antioxidant properties of hydroxy-flavones. , 1996, Free radical biology & medicine.

[74]  S. Kuo,et al.  Dietary flavonoid and cancer prevention: evidence and potential mechanism. , 1997, Critical reviews in oncogenesis.

[75]  G. Cole,et al.  Vitamin E protects nerve cells from amyloid βprotein toxicity , 1992 .

[76]  A. Axon,et al.  Levels of nitrite, nitrate, N-nitroso compounds, ascorbic acid and total bile acids in gastric juice of patients with and without precancerous conditions of the stomach. , 1991, Carcinogenesis.

[77]  Xianzhong Wu,et al.  Antioxidant and antiproliferative activities of common fruits. , 2002, Journal of agricultural and food chemistry.

[78]  K. Kohn,et al.  Activated neutrophils induce prolonged DNA damage in neighboring cells. , 1989, Carcinogenesis.

[79]  E. Melamed,et al.  Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier , 2001, Neuropharmacology.

[80]  G. Yarrington Molecular Cell Biology , 1987, The Yale Journal of Biology and Medicine.

[81]  Mei Sun,et al.  Antioxidant activity of betalains from plants of the amaranthaceae. , 2003, Journal of agricultural and food chemistry.

[82]  Mark P Mattson,et al.  Metal‐Catalyzed Disruption of Membrane Protein and Lipid Signaling in the Pathogenesis of Neurodegenerative Disorders , 2004, Annals of the New York Academy of Sciences.

[83]  H. Schipper Redox Neurology: Visions of an Emerging Subspecialty , 2004, Annals of the New York Academy of Sciences.

[84]  P. López-Jaramillo,et al.  The L-arginine: nitric oxide pathway. , 1993, Current opinion in nephrology and hypertension.

[85]  R. Floyd,et al.  Protective action of nitrone-based free radical traps against oxidative damage to the central nervous system. , 1997, Advances in pharmacology.

[86]  B. Halliwell,et al.  Role of free radicals and catalytic metal ions in human disease: an overview. , 1990, Methods in enzymology.

[87]  K. Hensley,et al.  Oxidative stress in brain aging Implications for therapeutics of neurodegenerative diseases , 2002, Neurobiology of Aging.

[88]  S. Singh,et al.  Neuroprotective effect of N-acetyl cysteine on hypoxia-induced oxidative stress in primary hippocampal culture , 2005, Brain Research.

[89]  A. Ceriello Oxidative stress and glycemic regulation. , 2000, Metabolism: clinical and experimental.

[90]  J. Baynes Role of Oxidative Stress in Development of Complications in Diabetes , 1991, Diabetes.